[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Sofosbuvir (CAS 1190307-88-0) Market Growth 2022-2028

March 2022 | 95 pages | ID: GAA9A738C62EEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Sofosbuvir (CAS 1190307-88-0) will have significant change from previous year. According to our (LP Information) latest study, the global Sofosbuvir (CAS 1190307-88-0) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Sofosbuvir (CAS 1190307-88-0) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Sofosbuvir (CAS 1190307-88-0) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Sofosbuvir (CAS 1190307-88-0) market, reaching US$ million by the year 2028. As for the Europe Sofosbuvir (CAS 1190307-88-0) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Sofosbuvir (CAS 1190307-88-0) players cover Teva Pharmaceutical Industries Ltd, DONG BANG FUTURE TECH & LIFE CO., LTD, Beaukev Pharma International Pvt.Ltd, and DEAFARMA, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Sofosbuvir (CAS 1190307-88-0) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
  • Purity ? 98%
  • Purity ? 98%
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
  • Adults Patients
  • Elderly Patients
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
  • Teva Pharmaceutical Industries Ltd
  • DONG BANG FUTURE TECH & LIFE CO., LTD
  • Beaukev Pharma International Pvt.Ltd
  • DEAFARMA
  • Tecoland
  • Anhui HaiKang Pharmaceutical Co. Ltd
  • Shanghai Haoyuan Chemexpress Co., Ltd
  • Beijing Kawin Technology Share-holding Co
  • Hangzhou Longshine Bio-Tech Co
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Sofosbuvir (CAS 1190307-88-0) Annual Sales 2017-2028
  2.1.2 World Current & Future Analysis for Sofosbuvir (CAS 1190307-88-0) by Geographic Region, 2017, 2022 & 2028
  2.1.3 World Current & Future Analysis for Sofosbuvir (CAS 1190307-88-0) by Country/Region, 2017, 2022 & 2028
2.2 Sofosbuvir (CAS 1190307-88-0) Segment by Type
  2.2.1 Purity ? 98%
  2.2.2 Purity < 98%
2.3 Sofosbuvir (CAS 1190307-88-0) Sales by Type
  2.3.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2017-2022)
  2.3.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue and Market Share by Type (2017-2022)
  2.3.3 Global Sofosbuvir (CAS 1190307-88-0) Sale Price by Type (2017-2022)
2.4 Sofosbuvir (CAS 1190307-88-0) Segment by Application
  2.4.1 Adults Patients
  2.4.2 Elderly Patients
2.5 Sofosbuvir (CAS 1190307-88-0) Sales by Application
  2.5.1 Global Sofosbuvir (CAS 1190307-88-0) Sale Market Share by Application (2017-2022)
  2.5.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue and Market Share by Application (2017-2022)
  2.5.3 Global Sofosbuvir (CAS 1190307-88-0) Sale Price by Application (2017-2022)

3 GLOBAL SOFOSBUVIR (CAS 1190307-88-0) BY COMPANY

3.1 Global Sofosbuvir (CAS 1190307-88-0) Breakdown Data by Company
  3.1.1 Global Sofosbuvir (CAS 1190307-88-0) Annual Sales by Company (2020-2022)
  3.1.2 Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Company (2020-2022)
3.2 Global Sofosbuvir (CAS 1190307-88-0) Annual Revenue by Company (2020-2022)
  3.2.1 Global Sofosbuvir (CAS 1190307-88-0) Revenue by Company (2020-2022)
  3.2.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Company (2020-2022)
3.3 Global Sofosbuvir (CAS 1190307-88-0) Sale Price by Company
3.4 Key Manufacturers Sofosbuvir (CAS 1190307-88-0) Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Sofosbuvir (CAS 1190307-88-0) Product Location Distribution
  3.4.2 Players Sofosbuvir (CAS 1190307-88-0) Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR SOFOSBUVIR (CAS 1190307-88-0) BY GEOGRAPHIC REGION

4.1 World Historic Sofosbuvir (CAS 1190307-88-0) Market Size by Geographic Region (2017-2022)
  4.1.1 Global Sofosbuvir (CAS 1190307-88-0) Annual Sales by Geographic Region (2017-2022)
  4.1.2 Global Sofosbuvir (CAS 1190307-88-0) Annual Revenue by Geographic Region
4.2 World Historic Sofosbuvir (CAS 1190307-88-0) Market Size by Country/Region (2017-2022)
  4.2.1 Global Sofosbuvir (CAS 1190307-88-0) Annual Sales by Country/Region (2017-2022)
  4.2.2 Global Sofosbuvir (CAS 1190307-88-0) Annual Revenue by Country/Region
4.3 Americas Sofosbuvir (CAS 1190307-88-0) Sales Growth
4.4 APAC Sofosbuvir (CAS 1190307-88-0) Sales Growth
4.5 Europe Sofosbuvir (CAS 1190307-88-0) Sales Growth
4.6 Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales Growth

5 AMERICAS

5.1 Americas Sofosbuvir (CAS 1190307-88-0) Sales by Country
  5.1.1 Americas Sofosbuvir (CAS 1190307-88-0) Sales by Country (2017-2022)
  5.1.2 Americas Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2017-2022)
5.2 Americas Sofosbuvir (CAS 1190307-88-0) Sales by Type
5.3 Americas Sofosbuvir (CAS 1190307-88-0) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Sofosbuvir (CAS 1190307-88-0) Sales by Region
  6.1.1 APAC Sofosbuvir (CAS 1190307-88-0) Sales by Region (2017-2022)
  6.1.2 APAC Sofosbuvir (CAS 1190307-88-0) Revenue by Region (2017-2022)
6.2 APAC Sofosbuvir (CAS 1190307-88-0) Sales by Type
6.3 APAC Sofosbuvir (CAS 1190307-88-0) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Sofosbuvir (CAS 1190307-88-0) by Country
  7.1.1 Europe Sofosbuvir (CAS 1190307-88-0) Sales by Country (2017-2022)
  7.1.2 Europe Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2017-2022)
7.2 Europe Sofosbuvir (CAS 1190307-88-0) Sales by Type
7.3 Europe Sofosbuvir (CAS 1190307-88-0) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Sofosbuvir (CAS 1190307-88-0) by Country
  8.1.1 Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales by Country (2017-2022)
  8.1.2 Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2017-2022)
8.2 Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales by Type
8.3 Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sofosbuvir (CAS 1190307-88-0)
10.3 Manufacturing Process Analysis of Sofosbuvir (CAS 1190307-88-0)
10.4 Industry Chain Structure of Sofosbuvir (CAS 1190307-88-0)

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Sofosbuvir (CAS 1190307-88-0) Distributors
11.3 Sofosbuvir (CAS 1190307-88-0) Customer

12 WORLD FORECAST REVIEW FOR SOFOSBUVIR (CAS 1190307-88-0) BY GEOGRAPHIC REGION

12.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size Forecast by Region
  12.1.1 Global Sofosbuvir (CAS 1190307-88-0) Forecast by Region (2023-2028)
  12.1.2 Global Sofosbuvir (CAS 1190307-88-0) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Sofosbuvir (CAS 1190307-88-0) Forecast by Type
12.7 Global Sofosbuvir (CAS 1190307-88-0) Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Teva Pharmaceutical Industries Ltd
  13.1.1 Teva Pharmaceutical Industries Ltd Company Information
  13.1.2 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Product Offered
  13.1.3 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.1.4 Teva Pharmaceutical Industries Ltd Main Business Overview
  13.1.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.2 DONG BANG FUTURE TECH & LIFE CO., LTD
  13.2.1 DONG BANG FUTURE TECH & LIFE CO., LTD Company Information
  13.2.2 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Product Offered
  13.2.3 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.2.4 DONG BANG FUTURE TECH & LIFE CO., LTD Main Business Overview
  13.2.5 DONG BANG FUTURE TECH & LIFE CO., LTD Latest Developments
13.3 Beaukev Pharma International Pvt.Ltd
  13.3.1 Beaukev Pharma International Pvt.Ltd Company Information
  13.3.2 Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Product Offered
  13.3.3 Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.3.4 Beaukev Pharma International Pvt.Ltd Main Business Overview
  13.3.5 Beaukev Pharma International Pvt.Ltd Latest Developments
13.4 DEAFARMA
  13.4.1 DEAFARMA Company Information
  13.4.2 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Product Offered
  13.4.3 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.4.4 DEAFARMA Main Business Overview
  13.4.5 DEAFARMA Latest Developments
13.5 Tecoland
  13.5.1 Tecoland Company Information
  13.5.2 Tecoland Sofosbuvir (CAS 1190307-88-0) Product Offered
  13.5.3 Tecoland Sofosbuvir (CAS 1190307-88-0) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.5.4 Tecoland Main Business Overview
  13.5.5 Tecoland Latest Developments
13.6 Anhui HaiKang Pharmaceutical Co. Ltd
  13.6.1 Anhui HaiKang Pharmaceutical Co. Ltd Company Information
  13.6.2 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Product Offered
  13.6.3 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.6.4 Anhui HaiKang Pharmaceutical Co. Ltd Main Business Overview
  13.6.5 Anhui HaiKang Pharmaceutical Co. Ltd Latest Developments
13.7 Shanghai Haoyuan Chemexpress Co., Ltd
  13.7.1 Shanghai Haoyuan Chemexpress Co., Ltd Company Information
  13.7.2 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Product Offered
  13.7.3 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.7.4 Shanghai Haoyuan Chemexpress Co., Ltd Main Business Overview
  13.7.5 Shanghai Haoyuan Chemexpress Co., Ltd Latest Developments
13.8 Beijing Kawin Technology Share-holding Co
  13.8.1 Beijing Kawin Technology Share-holding Co Company Information
  13.8.2 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Product Offered
  13.8.3 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.8.4 Beijing Kawin Technology Share-holding Co Main Business Overview
  13.8.5 Beijing Kawin Technology Share-holding Co Latest Developments
13.9 Hangzhou Longshine Bio-Tech Co
  13.9.1 Hangzhou Longshine Bio-Tech Co Company Information
  13.9.2 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Product Offered
  13.9.3 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.9.4 Hangzhou Longshine Bio-Tech Co Main Business Overview
  13.9.5 Hangzhou Longshine Bio-Tech Co Latest Developments

14 RESEARCH FINDINGS AND CONCLUSIONList of Tables
Table 1. Sofosbuvir (CAS 1190307-88-0) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Sofosbuvir (CAS 1190307-88-0) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Purity ? 98%
Table 4. Major Players of Purity ? 98%
Table 5. Global Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2022) & (MT)
Table 6. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2017-2022)
Table 7. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2017-2022) & ($ million)
Table 8. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Type (2017-2022)
Table 9. Global Sofosbuvir (CAS 1190307-88-0) Sale Price by Type (2017-2022) & (USD/MT)
Table 10. Global Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2022) & (MT)
Table 11. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2017-2022)
Table 12. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Application (2017-2022)
Table 13. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Application (2017-2022)
Table 14. Global Sofosbuvir (CAS 1190307-88-0) Sale Price by Application (2017-2022) & (USD/MT)
Table 15. Global Sofosbuvir (CAS 1190307-88-0) Sales by Company (2020-2022) & (MT)
Table 16. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Company (2020-2022)
Table 17. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Company (2020-2022)
Table 19. Global Sofosbuvir (CAS 1190307-88-0) Sale Price by Company (2020-2022) & (USD/MT)
Table 20. Key Manufacturers Sofosbuvir (CAS 1190307-88-0) Producing Area Distribution and Sales Area
Table 21. Players Sofosbuvir (CAS 1190307-88-0) Products Offered
Table 22. Sofosbuvir (CAS 1190307-88-0) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Sofosbuvir (CAS 1190307-88-0) Sales by Geographic Region (2017-2022) & (MT)
Table 26. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share Geographic Region (2017-2022)
Table 27. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Sofosbuvir (CAS 1190307-88-0) Sales by Country/Region (2017-2022) & (MT)
Table 30. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country/Region (2017-2022)
Table 31. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Sofosbuvir (CAS 1190307-88-0) Sales by Country (2017-2022) & (MT)
Table 34. Americas Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country (2017-2022)
Table 35. Americas Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country (2017-2022)
Table 37. Americas Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2022) & (MT)
Table 38. Americas Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2017-2022)
Table 39. Americas Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2022) & (MT)
Table 40. Americas Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2017-2022)
Table 41. APAC Sofosbuvir (CAS 1190307-88-0) Sales by Region (2017-2022) & (MT)
Table 42. APAC Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Region (2017-2022)
Table 43. APAC Sofosbuvir (CAS 1190307-88-0) Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Region (2017-2022)
Table 45. APAC Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2022) & (MT)
Table 46. APAC Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2017-2022)
Table 47. APAC Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2022) & (MT)
Table 48. APAC Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2017-2022)
Table 49. Europe Sofosbuvir (CAS 1190307-88-0) Sales by Country (2017-2022) & (MT)
Table 50. Europe Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country (2017-2022)
Table 51. Europe Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country (2017-2022)
Table 53. Europe Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2022) & (MT)
Table 54. Europe Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2017-2022)
Table 55. Europe Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2022) & (MT)
Table 56. Europe Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales by Country (2017-2022) & (MT)
Table 58. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2022) & (MT)
Table 62. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2022) & (MT)
Table 64. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Sofosbuvir (CAS 1190307-88-0)
Table 66. Key Market Challenges & Risks of Sofosbuvir (CAS 1190307-88-0)
Table 67. Key Industry Trends of Sofosbuvir (CAS 1190307-88-0)
Table 68. Sofosbuvir (CAS 1190307-88-0) Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Sofosbuvir (CAS 1190307-88-0) Distributors List
Table 71. Sofosbuvir (CAS 1190307-88-0) Customer List
Table 72. Global Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Region (2023-2028) & (MT)
Table 73. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Forecast by Region
Table 74. Global Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Country (2023-2028) & (MT)
Table 77. Americas Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Region (2023-2028) & (MT)
Table 79. APAC Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Country (2023-2028) & (MT)
Table 81. Europe Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Country (2023-2028) & (MT)
Table 83. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Type (2023-2028) & (MT)
Table 85. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Application (2023-2028) & (MT)
Table 89. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share Forecast by Application (2023-2028)
Table 92. Teva Pharmaceutical Industries Ltd Basic Information, Sofosbuvir (CAS 1190307-88-0) Manufacturing Base, Sales Area and Its Competitors
Table 93. Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Product Offered
Table 94. Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 95. Teva Pharmaceutical Industries Ltd Main Business
Table 96. Teva Pharmaceutical Industries Ltd Latest Developments
Table 97. DONG BANG FUTURE TECH & LIFE CO., LTD Basic Information, Sofosbuvir (CAS 1190307-88-0) Manufacturing Base, Sales Area and Its Competitors
Table 98. DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Product Offered
Table 99. DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 100. DONG BANG FUTURE TECH & LIFE CO., LTD Main Business
Table 101. DONG BANG FUTURE TECH & LIFE CO., LTD Latest Developments
Table 102. Beaukev Pharma International Pvt.Ltd Basic Information, Sofosbuvir (CAS 1190307-88-0) Manufacturing Base, Sales Area and Its Competitors
Table 103. Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Product Offered
Table 104. Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 105. Beaukev Pharma International Pvt.Ltd Main Business
Table 106. Beaukev Pharma International Pvt.Ltd Latest Developments
Table 107. DEAFARMA Basic Information, Sofosbuvir (CAS 1190307-88-0) Manufacturing Base, Sales Area and Its Competitors
Table 108. DEAFARMA Sofosbuvir (CAS 1190307-88-0) Product Offered
Table 109. DEAFARMA Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 110. DEAFARMA Main Business
Table 111. DEAFARMA Latest Developments
Table 112. Tecoland Basic Information, Sofosbuvir (CAS 1190307-88-0) Manufacturing Base, Sales Area and Its Competitors
Table 113. Tecoland Sofosbuvir (CAS 1190307-88-0) Product Offered
Table 114. Tecoland Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 115. Tecoland Main Business
Table 116. Tecoland Latest Developments
Table 117. Anhui HaiKang Pharmaceutical Co. Ltd Basic Information, Sofosbuvir (CAS 1190307-88-0) Manufacturing Base, Sales Area and Its Competitors
Table 118. Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Product Offered
Table 119. Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 120. Anhui HaiKang Pharmaceutical Co. Ltd Main Business
Table 121. Anhui HaiKang Pharmaceutical Co. Ltd Latest Developments
Table 122. Shanghai Haoyuan Chemexpress Co., Ltd Basic Information, Sofosbuvir (CAS 1190307-88-0) Manufacturing Base, Sales Area and Its Competitors
Table 123. Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Product Offered
Table 124. Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 125. Shanghai Haoyuan Chemexpress Co., Ltd Main Business
Table 126. Shanghai Haoyuan Chemexpress Co., Ltd Latest Developments
Table 127. Beijing Kawin Technology Share-holding Co Basic Information, Sofosbuvir (CAS 1190307-88-0) Manufacturing Base, Sales Area and Its Competitors
Table 128. Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Product Offered
Table 129. Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 130. Beijing Kawin Technology Share-holding Co Main Business
Table 131. Beijing Kawin Technology Share-holding Co Latest Developments
Table 132. Hangzhou Longshine Bio-Tech Co Basic Information, Sofosbuvir (CAS 1190307-88-0) Manufacturing Base, Sales Area and Its Competitors
Table 133. Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Product Offered
Table 134. Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 135. Hangzhou Longshine Bio-Tech Co Main Business
Table 136. Hangzhou Longshine Bio-Tech Co Latest Developments
List of Figures
Figure 1. Picture of Sofosbuvir (CAS 1190307-88-0)
Figure 2. Sofosbuvir (CAS 1190307-88-0) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate 2017-2028 (MT)
Figure 7. Global Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Sofosbuvir (CAS 1190307-88-0) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Purity ? 98%
Figure 10. Product Picture of Purity ? 98%
Figure 11. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type in 2021
Figure 12. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Type (2017-2022)
Figure 13. Sofosbuvir (CAS 1190307-88-0) Consumed in Adults Patients
Figure 14. Global Sofosbuvir (CAS 1190307-88-0) Market: Adults Patients (2017-2022) & (MT)
Figure 15. Sofosbuvir (CAS 1190307-88-0) Consumed in Elderly Patients
Figure 16. Global Sofosbuvir (CAS 1190307-88-0) Market: Elderly Patients (2017-2022) & (MT)
Figure 17. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2017-2022)
Figure 18. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Application in 2021
Figure 19. Sofosbuvir (CAS 1190307-88-0) Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Company in 2021
Figure 21. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Geographic Region in 2021
Figure 23. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Region (2017-2022)
Figure 24. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country/Region in 2021
Figure 25. Americas Sofosbuvir (CAS 1190307-88-0) Sales 2017-2022 (MT)
Figure 26. Americas Sofosbuvir (CAS 1190307-88-0) Revenue 2017-2022 ($ Millions)
Figure 27. APAC Sofosbuvir (CAS 1190307-88-0) Sales 2017-2022 (MT)
Figure 28. APAC Sofosbuvir (CAS 1190307-88-0) Revenue 2017-2022 ($ Millions)
Figure 29. Europe Sofosbuvir (CAS 1190307-88-0) Sales 2017-2022 (MT)
Figure 30. Europe Sofosbuvir (CAS 1190307-88-0) Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales 2017-2022 (MT)
Figure 32. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Revenue 2017-2022 ($ Millions)
Figure 33. Americas Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country in 2021
Figure 34. Americas Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country in 2021
Figure 35. United States Sofosbuvir (CAS 1190307-88-0) Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Sofosbuvir (CAS 1190307-88-0) Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Sofosbuvir (CAS 1190307-88-0) Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Sofosbuvir (CAS 1190307-88-0) Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Region in 2021
Figure 40. APAC Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Regions in 2021
Figure 41. China Sofosbuvir (CAS 1190307-88-0) Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Sofosbuvir (CAS 1190307-88-0) Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Sofosbuvir (CAS 1190307-88-0) Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Sofosbuvir (CAS 1190307-88-0) Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Sofosbuvir (CAS 1190307-88-0) Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Sofosbuvir (CAS 1190307-88-0) Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country in 2021
Figure 48. Europe Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country in 2021
Figure 49. Germany Sofosbuvir (CAS 1190307-88-0) Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Sofosbuvir (CAS 1190307-88-0) Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Sofosbuvir (CAS 1190307-88-0) Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Sofosbuvir (CAS 1190307-88-0) Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Sofosbuvir (CAS 1190307-88-0) Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country in 2021
Figure 56. Egypt Sofosbuvir (CAS 1190307-88-0) Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Sofosbuvir (CAS 1190307-88-0) Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Sofosbuvir (CAS 1190307-88-0) Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Sofosbuvir (CAS 1190307-88-0) Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Sofosbuvir (CAS 1190307-88-0) Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Sofosbuvir (CAS 1190307-88-0) in 2021
Figure 62. Manufacturing Process Analysis of Sofosbuvir (CAS 1190307-88-0)
Figure 63. Industry Chain Structure of Sofosbuvir (CAS 1190307-88-0)
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles


More Publications